FBRX
Forte Biosciences, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Forte Biosciences (FBRX) Stock: Buy, Sell, or Hold?
$76.99
+0.02 (+0.03%)
▲
5d:
+0.12%
30d:
+0.44%
90d:
+258.59%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (64%)
Quality Score
54/100
Position
FAIR
Forward P/E & Valuation
-19.5x
Next 12M consensus est.
Wall Street Target
$73.80
-4.1% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$76.78 / $77.00
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: FBRX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When FBRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: FBRX is currently trading at $76.99, which is considered fair based on recent price action.
Technical Outlook: Technically, FBRX is in a strong uptrend. The price is currently testing key support at $76.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FBRX is in a strong uptrend. The price is currently testing key support at $76.78. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 49/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
54/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Trading Range & Key Levels
Support Level
$76.78
Resistance Level
$77.00
Current Trend
Strong Uptrend
Technical data as of
Aug 26, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (49/100)
- NEUTRAL: Near Wall St target ($73.80)
- NEUTRAL: Bottoming setup forming (49/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
-19.52
Wall Street Target
$73.80
(-4.1%)
Share FBRX Analysis
Share this live FBRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (FBRX)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Jul 27, 2026
Daily AI digest
AI Retail Discussion Summary:
argenx is acquiring Forte Biosciences for approximately $2.2 billion, gaining the first-in-class anti-CD122 antibody FB102 and expanding its immunology pipeline.
Key Retail Themes:
M&A activity in the biotech sector
Expansion of argenx's immunology pipeline
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:42 AM ET
Data refreshes hourly during market hours. Next update: 9:42 AM
Data refreshes hourly during market hours. Next update: 9:42 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FBRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 37 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 43 HOLD |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 36 SELL |
|
NAMS
NewAmsterdam Pharma Comp… |
STRONG BUY
16 analysts |
$50 | 49 HOLD |
|
CGEM
Cullinan Oncology LLC |
STRONG BUY
12 analysts |
$35 | 57 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive FBRX Research Pages
